Pharmaceutical - Novo Nordisk, Licensing


Current filters:

Novo NordiskLicensing

Popular Filters

Emisphere earns $10 million on amended deal with Novo Nordisk


USA-based Emisphere Technologies (OTCBB: EMIS) says that it has agreed with Danish insulin giant Novo…

DiabetesEmisphereLicensingNovo NordiskPharmaceuticalResearch

Novo Nordisk to acquire Taiwanese osteo/RA technology


Danish insulin giant Novo Nordisk (NOV: N) has acquired rights to technology developed by a southern…

Anti-Arthritics/RheumaticsLicensingNovo NordiskPharmaceuticalResearch

Novo Nordisk in-licenses drug delivery technology from Caisson


Danish insulin giant Novo Nordisk (NVO: N) has entered into a development and license agreement with…

Caisson BiotechHeparinexLicensingNovo NordiskPharmaceutical

Pfizer and Biocon cancel biosimilars deal


Indian biotech firm Biocon (BSE: 532523) and global drugs behemoth Pfizer (NYSE: PFE) yesterday announced…

Asia-PacificBioconBiotechnologyDiabetesInsulinLicensingNovo NordiskPfizerPharmaceutical

Back to top